The global animal health market – which includes commercial animal products and companion animals such as pets – is experiencing significant growth driven by the convergence of two mega trends.
Across the wider animal health sector there has been significant M&A activity and this is expected to continue as larger companies look to acquire the unique products and capabilities of smaller players.
Case study: AniCura
In this publication we talk exclusively to Claus Bundgaard Nielsen, who along with his fellow partners sold his animal hospital, Aarhus Dyrehospital, to AniCura in a deal advised by Clearwater International. Claus explains the rationale behind the sale and the benefits it has brought. We also talk to Peter Dahlberg, President and CEO of AniCura about what is driving M&A activity in the animal health market and the future for the AniCura Group.5
International healthcare team
Clearwater International’s healthcare team has completed 72 transactions with a total value of over €3.6bn. The team has been a prolific transactor in the last two years completing 20 deals. The common feature of all of our transactions is the in-depth market knowledge within our Healthcare team and the global reach that we can bring to bear.6